Results 41 to 50 of about 29,631 (205)
Branch Retinal Vein Occlusion after Messenger RNA-Based COVID-19 Vaccine
Case Reports in Ophthalmology, 2022 Two days after the second dose of the messenger RNA-based COVID-19 vaccine (BNT162b2), a healthy 38-year-old man developed branch retinal vein occlusion (BRVO) in his left eye (OS).
Kazunobu Sugihara +2 more
doaj +1 more source
A racing heart post‐Pfizer/
Journal of Arrhythmia, 2022 Palpitations is one of the most common side effects experienced post-messenger-RNA COVID-19 vaccines. However, some patients experience significant symptoms and further workup needs to be considered. We present an interesting case of inappropriate sinus tachycardia in a fit gentleman who presented with worsening palpitations and elevated heart rate ...
Hooi Khee Teo +4 more
openaire +3 more sources
Is a single COVID-19 vaccine dose enough in convalescents ?
Human Vaccines & Immunotherapeutics, 2021 SARS-CoV-2 has infected more than 122 million persons worldwide. Most currently licensed COVID-19 vaccines require a two-dose course and many health systems are on a shortage of doses.
Daniele Focosi +2 more
doaj +1 more source
Side Effects Related to BNT162b2 and CoronaVac Vaccine Requiring Emergency Department Visit
Avicenna Journal of Medicine, 2022 Background Currently, the most effective method in the fight against coronavirus disease 2019 (COVID-19) is vaccination against the disease. However, there are hesitations among society concerning the safety and side effects of COVID-19 vaccines.
Erdal Yavuz +6 more
doaj +1 more source
Lymphocyte levels following COVID-19 vaccine BNT162b2
, 2021 Introduction: The BNT162b2 vaccine has been shown to be effective in reducing the incidence, severity and mortality of Coronavirus Disease 2019 (COVID-19).
Oren Miron, Nadav Davidovitch
core +1 more source
, 2023 Background: Comparative analyses of SARS-CoV-2-specific immune responses elicited by diverse primeboost regimens are required to establish efficient regimens for the control of COVID-19.
Jae-Hoon Ko +13 more
core +1 more source
Safety and BNT162b2 mRNA COVID-19 vaccination.
Acta bio-medica : Atenei Parmensis, 2021 n/a.
Joob, Beuy, Wiwanitkit, Viroj
openaire +2 more sources
Adverse events reported following BNT162b2 vaccine administration.
, 2023 Adverse events reported following BNT162b2 vaccine administration.
Ameer Hohlfeld (6059231) +10 more
core +1 more source
Durability of immune responses to the BNT162b2 mRNA vaccine
Med, 2022 Antibody responses to the Pfizer-BioNTech mRNA vaccine waned substantially 6 months after the second vaccination.
Mehul S. Suthar +20 more
openaire +2 more sources
Persistence of Anti-SARS-CoV-2 Spike IgG Antibodies Following COVID-19 Vaccines
Infection and Drug Resistance, 2022 Naif Khalaf Alharbi,1,2 Jaffar A Al-Tawfiq,3– 5 Amal Alwehaibe,1 Mohamed W Alenazi,1 Abdulrahman Almasoud,1 Abdullah Algaisi,6 Fahad A Alhumaydhi,7 Anwar M Hashem,8,9 Mohammed Bosaeed,1,2,10 Suliman A Alsagaby11 1Vaccine Development Unit, King Abdullah ...
Alharbi NK +9 more
doaj